Modular Facility Proof-of-Concept for Multi-Modal Bioprocessing: an innovative solution
This webinar describes the collaboration of Merck KGaA, Life Science, Germany/MilliporeSigma, and G-CON to develop a proof-of-concept facility design that enables multi-modal bioprocessing with greater flexibility and agility which facilitates tech transfer and future expansion. Details about the design, timelines, and cost repartition will be included.
In this presentation you will explore:
• How to develop a proof-of-concept facility design that supports multi-modal bioprocessing
• Details about the specific design, timelines, and costs
• How this modular facility approach can be leveraged for your specific requirements
Register here
Business Development Manager at G-CON
Thomas Hauser is Business Development Manager for G-CON Manufacturing within the EMEA region. He works to educate the market for offsite prefabricated and prequalified factory and clean-room solutions in a drive to bring forward the pharmaceutical facility of the future. He also supports companies in the life science segment, mainly for expansion strategies, strategic facility implementation, start-up support, and pharmaceutical packaging supply and technologies. Before 2020, Thomas worked in various leading global positions, dealing with the global life science Industry.
Latest posts by Thomas Hauser (see all)
Senior Consultant, EMEA Traditional Modalities at Bioprocessing Strategy Operationalization
Jérome Dalin holds an Msc/engineering degree in industrial manufacturing and biological engineering. He is Senior Consultant - EMEA Traditional Modalities, Bioprocessing Strategy Operationalization for Merck KGaA, Life Science, Germany/MilliporeSigma.
He started his career at Sanofi Pasteur 20 years ago, working in France on vaccine process development. In 2013, he joined our company to manage bioprocessing sales with vaccine project coordination at a global level. In his current role, Jérome is leading strategic initiatives and supporting go-to-market strategies with a special focus on traditional modalities.
He started his career at Sanofi Pasteur 20 years ago, working in France on vaccine process development. In 2013, he joined our company to manage bioprocessing sales with vaccine project coordination at a global level. In his current role, Jérome is leading strategic initiatives and supporting go-to-market strategies with a special focus on traditional modalities.
Latest posts by Jérome Dalin (see all)
